Efficacy and Safety of Travoprost 0.004% Versus Tafluprost 0.0015% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions

Glaucoma

Interventions

DRUG

Travoprost 0.004% ophthalmic solution (TRAVATAN)

One drop in the qualifying eye(s) each evening at 6:00 PM for 6 weeks, topical administration

DRUG

Tafluprost 0.0015% ophthalmic solution

One drop in the qualifying eye(s) each evening at 6:00 PM for 6 weeks, topical administration